ASTRAZENECA's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday.
Several countries have already altered their advice after previous research indicated that — in a tiny number of cases — thrombosis with thrombocytopenia syndrome can be a possible side effect of Covid vaccines that use an adenovirus vector, or "engineered" virus, such as those from AstraZeneca and Johnson & Johnson.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.